Current stock page

Catalysts

TRVI Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

TRVITrevi Therapeutics, Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Sector Leader

NeutralEdge 10/10
$13.65+$0.03 (+0.22%)

Latest quote

  • Momentum
    52
  • Value
    —
  • Quality
    82
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 63/100

Momentum 52/100 and sentiment — before the next covered event.

Recent coverage
3 articles

Updated Nov 15, 2026 · Sentiment 28.73%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 52/100AIQ Edge 10/10 Sector Leader
Beat rate
75%
6 of 8 reported periods
Average surprise
+10.2%
Across covered historical reports
Latest result
+1.3%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$0.13-$0.13+1.3%——
Aug 6, 2026—-$0.11-$0.11-0.5%——
May 5, 2026—-$0.07-$0.09-28.6%——
Mar 17, 2026—-$0.10-$0.06+40.0%——
Nov 13, 2025—-$0.10-$0.08+20.0%——
Aug 7, 2025—-$0.10-$0.09+10.0%——
May 8, 2025—-$0.13-$0.09+30.8%——
Mar 18, 2025—-$0.12-$0.11+8.3%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
11
Buy
12-month analyst target
—
— versus current price
Based on 11 analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
—
—
Average target
—
—
High target
—
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score52

Where event reaction would show up first.

AIQ score63/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
11

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
1
Negative
0
seekingalpha.com · Nov 10, 2026

Trevi Therapeutics, Inc. (TRVI) Q3 2026 Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q3 2026 Earnings Call November 9, 2026 4:30 PM ESTCompany ParticipantsJennifer Good - Co-Founder, CEO, President, &...

seekingalpha.com · Sep 16, 2026

Trevi Therapeutics, Inc. (TRVI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Trevi Therapeutics, Inc. (TRVI) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 4:50 PM EDTCompany ParticipantsJennifer Good -...

seekingalpha.com · Aug 20, 2026

Trevi Therapeutics: A Specialty Beachhead Creates A Chronic Cough Platform (NASDAQ:TRVI)

Trevi Therapeutics leverages Haduvio's dual mechanism to target IPF-related chronic cough. Click here to read why TRVI stock is a Buy.

Open full news and sentiment

TRVI Catalysts FAQ

What are the next catalysts for TRVI stock?

TRVI's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move TRVI stock?

Upcoming events that could move TRVI include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could TRVI's next earnings report affect the stock?

TRVI's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive TRVI stock higher?

TRVI could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt TRVI stock?

TRVI could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.